Tampa, FLNow Enrolling

Uveal Melanoma Clinical Trial in Tampa, FL

Access cutting-edge uveal melanoma treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.

Expert Care

Access uveal melanoma specialists in Tampa at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related uveal melanoma treatment provided free

About This Uveal Melanoma Study in Tampa

The goal of this clinical research study is to find out if Cemiplimab plus Ziv-Aflibercept is safe and effective in treating your condition of metastatic (spread to other parts of your body) uveal melanoma. This research study will test the study drugs to see if the combination of Cemiplimab plus Ziv-Aflibercept can make tumors shrink or stop growing.

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Apply for This Tampa Location

Check if you qualify for this uveal melanoma clinical trial in Tampa, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Uveal Melanoma Treatment Options in Tampa, FL

If you're searching for uveal melanoma treatment options in Tampa, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced uveal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Uveal Melanoma?

  • Access to new treatments before they're widely available
  • Receive care from leading uveal melanoma specialists in Tampa
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel